echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > FDA Grants Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue

    FDA Grants Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue

    • Last Update: 2022-02-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Antares Pharma announced that the U.


    The ATRS-1902 development program supports the use of Vai's novel proprietary auto-injector platform to deliver a liquid-stable formulation of hydrocortisone for the proposed indication: treatment of acute adrenal insufficiency (known as adrenal crisis) in adults and adolescents


    Adrenal crisis, also known as acute adrenal insufficiency, is a clinical syndrome caused by acute failure of adrenal cortex function due to absolute or relative insufficient secretion of adrenal cortical hormones under the action of various reasons


    Just recently, Antares Pharma announced positive results from a phase I crossover study of ATRS-1902, which met its primary endpoint: In 32 healthy adults, ATRS-1902 (100 mg) provided a synergistic effect with reference drug Solu Cortef® ( 100 mg) comparable pharmacokinetic profile


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.